Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection
about
Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteinsInvolvement of creatine kinase B in hepatitis C virus genome replication through interaction with the viral NS4A proteinHepatitis C virus hijacks host lipid metabolismIntramembrane processing by signal peptide peptidase regulates the membrane localization of hepatitis C virus core protein and viral propagationImpact of lipids and lipoproteins on hepatitis C virus infection and virus neutralizationTargeting host factors: A novel rationale for the management of hepatitis C virusLow pH-dependent Hepatitis C Virus Membrane Fusion Depends on E2 Integrity, Target Lipid Composition, and Density of Virus ParticlesHepatitis C Virus entry: the early steps in the viral replication cycleRole of Oxysterol Binding Protein in Hepatitis C Virus infectionTemporal Proteome and Lipidome Profiles Reveal Hepatitis C Virus-Associated Reprogramming of Hepatocellular Metabolism and BioenergeticsPalmitoylation of Hepatitis C Virus Core Protein Is Important for Virion ProductionInvolvement of Ceramide in the Propagation of Japanese Encephalitis VirusMetabolomic profile of hepatitis C virus-infected hepatocytesAntiviral activity of glycyrrhizin against hepatitis C virus in vitroAn integrated transcriptomic and meta-analysis of hepatoma cells reveals factors that influence susceptibility to HCV infectionViperin is an iron-sulfur protein that inhibits genome synthesis of tick-borne encephalitis virus via radical SAM domain activityRespiratory syncytial virus glycoprotein G interacts with DC-SIGN and L-SIGN to activate ERK1 and ERK2.The missing pieces of the HCV entry puzzle.Characterization of Lassa virus glycoprotein oligomerization and influence of cholesterol on virus replication.Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation.Lipoprotein lipase inhibits hepatitis C virus (HCV) infection by blocking virus cell entrySerum sphingolipids reflect the severity of chronic HBV infection and predict the mortality of HBV-acute-on-chronic liver failureThe rate of hepatitis C virus infection initiation in vitro is directly related to particle density.Polyunsaturated liposomes are antiviral against hepatitis B and C viruses and HIV by decreasing cholesterol levels in infected cellsIdentification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor.Sphingomyelin activates hepatitis C virus RNA polymerase in a genotype-specific manner.Hepatocyte nuclear factor 4α and downstream secreted phospholipase A2 GXIIB regulate production of infectious hepatitis C virusSelf-enhancement of hepatitis C virus replication by promotion of specific sphingolipid biosynthesis.A cell culture adapted HCV JFH1 variant that increases viral titers and permits the production of high titer infectious chimeric reporter viruses.Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome.Co-expression analysis of differentially expressed genes in hepatitis C virus-induced hepatocellular carcinoma.Activation of TGF-β1 promoter by hepatitis C virus-induced AP-1 and Sp1: role of TGF-β1 in hepatic stellate cell activation and invasion.Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes.Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP).Protein kinase D negatively regulates hepatitis C virus secretion through phosphorylation of oxysterol-binding protein and ceramide transfer proteinCytomegalovirus-mediated activation of pyrimidine biosynthesis drives UDP-sugar synthesis to support viral protein glycosylationTargeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus.Farnesyl-diphosphate farnesyltransferase 1 regulates hepatitis C virus propagation.Cholesterol depletion of hepatoma cells impairs hepatitis B virus envelopment by altering the topology of the large envelope proteinDetergent-resistant membrane association of NS2 and E2 during hepatitis C virus replication
P2860
Q24301976-0F29E922-40DD-47E1-935E-525A1DF75A44Q24317879-5C10790D-EF99-435A-BC8B-D16A96C54893Q24652319-ADEB250D-890A-4AC0-A7F8-FDFB95D0E7B5Q24658154-EC28DB6E-4DBB-4253-B10F-2069EFC7EC4DQ26864485-F0E76AC9-3BC2-4877-9282-E259579ED3FFQ27488999-C27B0428-E19E-4008-888B-C2D7D63F9802Q27489056-80AF40FB-D4B0-4911-B201-3C1F8B716758Q27489242-D9828363-560D-4245-B717-4094BF1D0BB2Q27489539-7D8C3673-6475-4A37-A248-C9FABAF6A66CQ27490520-F504B068-4331-4A53-8246-708F5AA5005EQ27490522-AE77FC11-4F82-4DE2-8569-7FCC79AC55C6Q27490958-686577AC-5E3D-4AF8-B664-E756FC17579BQ28476531-8916484B-425A-411F-8A04-11B49F399BBAQ28534716-5AF56880-AE70-4256-9FA8-D7C2ED2E0537Q28743482-400D128E-5022-4F4A-BAF2-A8A2E7A79FA2Q29147519-598E0B2C-20B8-458D-9281-FE2928BD358DQ30425776-726E0ABB-4C8C-470E-875B-B9C79696B8ABQ33360674-6243AF3E-B56A-48D3-9A1E-06CE598785DFQ33558319-D4A27B37-ACEB-44B1-8995-098EF1C1109AQ34020915-7FDDAC93-2472-4419-A640-D8A0A7B436B0Q34062532-E0455F07-DB9F-48ED-A9AA-C735FF7D8473Q34066622-893709F7-5790-401C-8F00-F3C788423595Q34158687-9E4D6D58-A3AF-49C5-854C-D3DE90B4CAF0Q34182524-46359E35-E765-4DC3-A3F4-7DE6981376DCQ34245963-6113F6FC-6FD8-4759-B71C-A760300C0CE6Q34296036-3AA0C931-0B31-4E96-BDBB-4256B91DCABEQ34381310-8DF00FCA-D14F-4480-A99D-F0490B90BC9BQ34390521-BC221F3F-7ED3-4BF2-8790-E2998C8FFAFDQ34427768-852AC9A9-5736-44B3-82A6-0A4FA4D7FA77Q34509568-65FABC53-68A1-42EA-B223-EC034ED5E41BQ34540886-B3EFF111-4C5D-4435-959E-CD728E984821Q34598615-B0D185EF-B453-42B9-AB34-B970084C25D6Q34636137-92B4A5CF-A56D-4036-A02A-FAF1D3E09B0AQ34693445-D266D903-EC01-44D7-8AF5-C4BECA9FBB41Q34719596-2CC5C349-12E3-492D-8802-361AD48535F9Q34752212-60F0628E-8644-4C37-B551-6781BD213E33Q35115534-94FAC150-A6C5-4508-A6C2-6246C4DA93CAQ35137045-E968A253-EA2D-43AA-9CF5-78F1A2AAA687Q35599384-70E9564C-3FB0-4841-8652-46AB7DA8C7D7Q35641053-DB98A208-0EBE-4D25-BFAD-C5F012D72A43
P2860
Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Critical Role of Virion-Associ ...... in Hepatitis C Virus Infection
@ast
Critical Role of Virion-Associ ...... in Hepatitis C Virus Infection
@en
Critical Role of Virion-Associ ...... in Hepatitis C Virus Infection
@nl
type
label
Critical Role of Virion-Associ ...... in Hepatitis C Virus Infection
@ast
Critical Role of Virion-Associ ...... in Hepatitis C Virus Infection
@en
Critical Role of Virion-Associ ...... in Hepatitis C Virus Infection
@nl
prefLabel
Critical Role of Virion-Associ ...... in Hepatitis C Virus Infection
@ast
Critical Role of Virion-Associ ...... in Hepatitis C Virus Infection
@en
Critical Role of Virion-Associ ...... in Hepatitis C Virus Infection
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Critical Role of Virion-Associ ...... in Hepatitis C Virus Infection
@en
P2093
Hideki Aizaki
Hideki Tani
Hiromichi Hara
Kenichi Morikawa
Kentaro Hanada
Kyoko Saito
Masahiro Nishijima
Masayoshi Fukasawa
Tatsuo Miyamura
Tetsuro Suzuki
P2860
P304
P3181
P356
10.1128/JVI.02530-07
P577
2008-06-01T00:00:00Z